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Abstract
Objectives—To determine perceived barriers and facilitators to a career in rheumatology 
research, examine factors leading rheumatologists to leave an academic research career, and solicit 
ways to best support young physician-scientists.
Methods—A web-based survey was conducted among the domestic American College of 
Rheumatology (ACR) membership from January–March 2014. Inclusion criteria were ACR 
membership and an available email address. Non-rheumatologists were excluded. The survey 
assessed demographics, research participation, barriers and facilitators to a career in research, 
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reasons for leaving a research career (when applicable), and ways in which the ACR could support 
junior investigators. Content analysis was used to extract relevant themes.
Results—Among 5,448 ACR domestic members, 502 responses were obtained (9.2% response 
rate). After exclusions (38 incomplete, 2 duplicates, 32 non-rheumatologists), 430 responses were 
analyzed. Participants included fellows, young investigators, established investigators, mentors, 
clinicians, and those who previously pursued a research career but have chosen a different career 
path. Funding and mentoring were the most highly ranked barriers and facilitators. Protection from 
clinical and administrative duties, institutional support and personal characteristics such as 
resilience and persistence were also ranked highly. The most commonly cited reasons for leaving 
an academic research career were difficulty obtaining funding and lack of department or division 
support.
Conclusion—This is the first study to examine barriers and facilitators to a career in 
rheumatology research from the perspectives of diverse groups of rheumatologists. Knowledge of 
such barriers and facilitators may assist in designing interventions to support investigators during 
vulnerable points in their career development.
Keywords
young investigator; rheumatology; research; survey
“It is the progressive decline in the number of new entries that constitutes the 
danger to the survival of the species in the numbers and quality needed to 
maximize the rate of progress against the serious diseases of mankind.”
James B. Wyngaarden, M.D. Bull. N.Y. Acad. Med. 
1981: 57(6): 415–426
In 1979, Dr. Wyngaarden, future director of the National Institutes of Health (NIH), called 
the physician-scientist an “endangered species” as he noted rapid declines over the previous 
two decades in the number of clinicians also trained in research methodology and 
simultaneously acting as a physician and “serious scientist”.(1) While the American medical 
system has evolved and funding sources have risen and fallen in the decades following Dr. 
Wyngaarden’s paper, the same concern about the small pool of physician-scientists remains. 
Francis Collins, MD, current director of the NIH, recently commissioned a Physician 
Scientist Workforce Working Group (PSWWG) with “analyzing the current composition 
and size of the physician-scientist biomedical workforce and making recommendations for 
actions that NIH should take to help sustain and strengthen a robust and diverse PSW.” The 
executive summary, published in June 2014, reports a shrinking NIH budget compared to 
previous levels of funding, an aging physician-scientist workforce, and a decline in the 
number of new physician scientists entering the workforce.(2) Additionally, a high rate of 
attrition exists among those initially choosing a research career with significant drop out 
between receipt of an NIH career development award (K series) and obtaining an R01-level 
project grant.(2)
Physician scientists in rheumatology have dramatically improved our understanding of 
rheumatic diseases, directly propelling the unprecedented growth of effective therapies such 
as biologics in the past 15 years. The aging workforce and smaller number of physician-
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scientists is particularly a concern in rheumatology.(3) Continued understanding of 
rheumatic diseases and generation of novel therapeutics could thus be in jeopardy. 
Therefore, the development and cultivation of young rheumatology investigators is critical 
to the future of rheumatology.
While research and salary support for clinician investigators is clearly a concern, the NIH 
PSWWG notes that other issues beyond funding also contribute. However, the specific 
barriers to and facilitators for maintaining a career in research remain unclear. If such 
barriers and facilitators are identified, strategies may be developed to target obstacles and 
better support investigators, particularly young investigators launching their career.
The objectives of this study were to a) determine the perceived barriers and facilitators to a 
career in rheumatology research, b) examine factors leading to rheumatologists leaving a 
career in research, and c) determine how the American College of Rheumatology can best 
support young investigators through the early part of their career.
SUBJECTS AND METHODS
Participants
We conducted a survey among the American College of Rheumatology (ACR) membership 
living in the United States. Inclusion criteria included 1) current or previous fellowship in 
rheumatology; 2) membership in the ACR; and 3) an available email address. Non-
rheumatologist members of the ACR were excluded.
Survey Instrument
The survey instrument was developed through the use of a Delphi method (explained in 
Supplemental Figure 1). The full survey is available in the supplementary material. The 
instrument included items reflecting demographics including age, sex, under-represented 
minority status, current position and job type (e.g. academics, private practice, industry), 
academic rank if applicable, and year entering rheumatology fellowship. Branching logic 
was used to identify current investigators, research mentors and rheumatologists who have 
left research careers. Reasons for leaving a career in research were solicited both via a list of 
options and through free text comments. Next, participants were asked to rank the top ten 
barriers and top ten facilitators of a career in rheumatology research (ranked from 1–10). 
Participants were asked to select useful formats for providing support to young investigators 
(e.g. workshops, webinars, etc.). Free text responses solicited ways in which the ACR can 
best support young investigators and any additional comments.
Survey Administration
Surveys were sent on January 15, 2014 and closed March 15, 2014 with one reminder email 
on February 12, 2014. REDCap software was used to administer the surveys anonymously 
via an email with a link to a web-based survey. Participants completing the survey were 
eligible to enter a drawing for complimentary registration for the 2014 ACR/ARHP Annual 
Meeting in Boston.
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After excluding incomplete surveys and duplicates, demographics were summarized. 
Barriers and facilitators were categorized as important if ranked as 1, 2, or 3 of 10. The 
proportion of “important” ratings was reported for each barrier and facilitator. We then 
examined whether individual categories of participants (young investigators, mentors, 
fellows, and those who left a career in research) rated these barriers and facilitators 
differently than the remainder of the participants using a chi-squared test.
Content analysis(4) was performed for free text comments for a) reasons for leaving a 
research career, b) ways in which the ACR can support young investigators and c) general 
comments. Two coders (AO and YJ) developed a coding list (supplemental document 2) and 
iteratively applied these codes to the comments. Discrepancies were resolved through 
discussion with a third coder (UM). Percent agreement between AO and YJ was 98%. 
Themes that emerged from the qualitative responses were discussed among the study team 
and presented in the text.
Ethics approval
This study was approved by the University of Pennsylvania Institutional Review Board.
RESULTS
Survey participants
Among 5,448 ACR domestic members, 502 responses were obtained within the 8-week time 
frame (9.2% response rate). Among the participants, 32 were excluded as they were not 
rheumatologists, 38 were incomplete, and 2 duplicates were identified and excluded.
The final number of responses for analysis was 430. This included 309 adult 
rheumatologists, 62 pediatric rheumatologists, 42 adult rheumatology fellows, and 17 
pediatric rheumatology fellows. Demographics of the participants are included in Table 1. 
The majority of participants (71%) were working in academic medical centers. Among those 
with academic affiliations, 34 were instructors (or equivalent), 102 were assistant professors, 
58 were associate professors and 89 were professors.
Among survey participants, 171 (40%) reported actively pursuing a career in research (147 
faculty, 24 fellows). Of these, 64% were female. Types of research are shown in Table 1. 
Additionally, 52% of those actively pursuing research considered themselves a young 
investigator (defined as within 6 years of completing fellowship), and 44% indicated they 
were a mentor to a young investigator. While median percent effort dedicated to research 
was 15% (IQR 2–70%) among all participants, young investigators reported a median 
percent effort dedicated to research of 75% (IQR 70–80%).
Participants who have left a research career
Ninety-seven participants (23%) indicated that they had previously pursued a career in 
research but decided to switch career paths. This career change occurred a median of 10 
years ago (IQR 3–20) with a median transition point 7 years after fellowship (IQR 2–14) 
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(supplemental table 2). Previous research types and current positions are presented in Table 
2. Approximately half of participants were female. The most commonly reported reasons for 
leaving research were difficulty obtaining funding and lack of department or division 
support. In free text comments (N=51), participants cited additional reasons for leaving 
research including great clinical burden and insufficient protected time to be successful in 
research endeavors, financial factors (e.g. difficulty supporting family financially, difficulty 
covering loans with low salary), lack of mentorship, an unsupportive environment or 
institution, and personal reasons (e.g. new opportunities in administration, teaching and/or 
clinical care, need to move to a new geographic area without opportunities for research, 
increasing age, need for increased job security, and fear of having to move if not successful 
in obtaining funding or achieving tenure). For example:
“I had to see more patients to support my salary in academic medicine. This made 
it difficult to pursue research. The university used to pay large part of our salary, 
but they stopped doing that, requiring rheumatologists to see patients to generate 
their income.”
“I had to move for family reasons. I would have preferred moving to academia in 
the geographic region of interest, but there was not a realistic amount of protected 
time available in the jobs I considered to be able to conduct research. Also, because 
of the number of years spent with inadequate compensation, I needed higher pay to 
support putting the kids through college.”
When asked what would have kept these rheumatologists in research, the most common 
responses included increased protected time and availability of internal grant funding 
mechanisms. Analysis of free text comments revealed additional issues including the need 
for job security, improved mentorship, less politics, and more supportive institutional 
environments. For example:
“Job security was what drove me out of academics. I was at a high-powered 
academic center and I loved it, but I calculated my odds of getting tenure at about 
50%. RO1 funding at NIAID at that time was under 10% and the rule for tenure at 
my institution, as I understood it, was 2 grants. MANY junior faculty were not 
getting tenure. My kids would have been in the middle of high school when my 
time for a tenure decision arrived, and I decided not to risk having to move them.”
Barriers and Facilitators
Barriers and facilitators of a career in research are outlined in Figures 1 and 2 respectively. 
The most highly ranked barrier and facilitator of a career in research was funding. This was 
of significantly greater concern to young investigators than other participants. After funding, 
the next most commonly reported barriers were clinical workload, insufficient protected 
time, lower salary, and lack of institutional research infrastructure. Facilitators to a career in 
research, aside from sufficient funding, were protected research time, outstanding mentors, 
institutional support and funding for young investigators, as well as personal skills or traits 
such as hard work, resilience, initiative, persistence and passion for the job.
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We next examined differences in the frequency of barriers and facilitators reported by 
subgroups (Supplemental Table 1). Beyond funding, participants who had left a career in 
research were significantly more likely to report lack of institutional research infrastructure, 
lack of access to key people in the field, lack of diverse mentorship, local politics or conflict, 
poor relationship with the division chief, and lack of a clear career development pathway as 
important barriers and noted formal research training and ability to establish a niche as 
important facilitators. Fellows were more likely to report presentation skills and difficulty 
establishing a niche as important barriers.
Evaluation of free text comments revealed only a few additional themes. Several participants 
(N=8) indicated that gender issues still remained a barrier in pursuing a career in research. 
Others indicated that the need to care for young children and inability to allow flexibility in 
grants for time off to have children and part-time work prevented their continuing research 
careers.
“The majority of ACR leadership seems to be men, while younger members are 
more likely to be women. ACR should also have a program for young women 
investigators who go through pregnancy... etc.”
“The 6 year from fellowship early investigator definition disadvantages young 
women with babies/young kids during that time frame from participating in on site 
workshops.”
“I was a classic example of the female academic who falls off the tenure track. “
“There is no room at the academic table for us lowly clinician educators or for 
women who still have to deal with the numerous micro hits that torpedo our 
careers.”
”When I was a fellow, male fellows were offered academic positions with several 
year contracts, but female fellows were offered only 1 year contracts.”
A fear of failure or lack of confidence in abilities was also reported by two participants. 
Lack of institutional infrastructure for research and lack of knowledge about the needs of 
young investigators on the part of both the division chiefs and fellowship directors were 
cited as barriers.
Numerous participants indicated that clinical workload and administrative duties are a 
significant burden to researchers. For example:
“Why does everyone in academia have to do everything (teach, research, write, see 
patients?) Academia needs to re-examine the way things have 'always' been done.”
“Keeping junior faculty researchers productive despite the ever increasing demands 
that clinical work places on part time clinical faculty, including administrative 
duties required for CME, compliance, ICD-10 training, MOC, etc., is a significant 
burden.”
Some participants noted that the environment for careers in research is changing. For 
example:
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“The landscape has changed dramatically over my career. Most importantly, it has 
become harder to obtain funding, but almost as important, commitment to family 
has grown, in part because the majority of our trainees and young faculty are 
women but also because this has become more important to men. Thus, while there 
used to be an issue of balancing time for research with time for clinical care and 
teaching, there is now a greater issue of balancing time for family. I think that this 
is a good thing, but it is nonetheless an issue.”
With regard to facilitators, several participants noted that successful researchers require all 
or many of the facilitators listed.
“A successful young investigator needs to have ALL of the things listed above. If a 
young investigator is missing ANY of them (funding, time, mentorship, work ethic/
passion, family support), then they will fail.”
Supporting young investigators and improving the research environment
Participants were asked to give a free text answer to the question, “How can the ACR best 
support young investigators?” and a free text space was available for additional open 
comments. A total of 632 comments from the two items were reviewed. Content analysis 
revealed numerous themes related to improving the research career landscape for young 
investigators, many of which were directed at efforts the ACR could pursue to improve 
support for young investigators (Table 3). These responses were categorized as follows: 
funding, mentoring, career development and skill building, increase interest in and 
sustainability of research as a career, improve the research environment for young 
investigators, and miscellaneous. Overall, participants were supportive of the ACR’s current 
endeavors.
“Continue the strong funding support options available through the Rheumatology 
Research Foundation - these are critical with the shrinking NIH portfolio.”
The most commonly reported theme was the need for increased funding, particularly for 
young investigators but also increased pilot funding from the ACR extended to diseases 
other than inflammatory arthritis and bridge funding with attention to the K-to-R transition. 
Participants also suggested increasing the salary support from grants, including federally 
funded grants:
“$75K for a K award is not sufficient to support a salary and institutions do not 
provide money to support the gap. Thus, K award holders spread themselves thin to 
get more grants to provide salary support rather than spending the 75% protected 
time on the specific K award research project. Thus, allowing for overlapping funds 
is important.”
Participants encouraged continuation and expansion of advocacy efforts to increase NIH 
funding directed toward rheumatic diseases.
“Advocacy for arthritis research funding at NIH.”
“Continued federal lobby[ing] to interest lawmakers in medical research - we are 
really not considered in any political budget discussions.”
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“. . . Highlight the potential benefits to be derived from research . . . and the 
importance . . . in ultimately furthering the field. The public needs to know, and 
perhaps become energized to help push for research dollars and support.”
The need for mentoring was the second most commonly reported theme. Participants 
suggested developing a structured, cross-institutional mentoring program for interested 
researchers and to similarly increase networking for young investigators with experienced 
investigators. Furthermore, many participants also noted that support for mentors is also 
important for the development of young investigators.
“My primary concern is not direct support for the trainees but rather the available 
pool of mentors - ever shrinking with limited funding and the exodus of talented 
rheumatology researchers away from academic medicine. So to me, in order to 
adequately support trainees we need to make big steps to facilitate the ability of 
'veteran' researchers to remain intact.”
“If there are lapses in funding, then an entire career in academic medicine is lost, as 
institutions force faculty to either leave or drop research altogether. Those of us 
who are still standing are absolutely overwhelmed with mentoring responsibilities, 
even as junior faculty, since there is a huge gap in mid-level faculty who have left 
for practice or industry. We are happy to do our research and mentor those after us, 
but not if a single year of lapsed funding results in job loss.”
Other common themes included the need for development of grant writing skills through 
workshops, webinars, and mentorship, development of a community for young investigators 
to provide peer mentoring, encouragement for formal research training, development of 
standards for research training in fellowship or a core research curriculum, continued 
support for career development workshops, collaboration among institutions, support for 
protected time and better compensation for investigators. Participants also suggested 
development of a loan repayment program, early research exposure for medical students and 
residents and more comprehensive research exposure early in fellowship. Finally, 
participants suggested that the ACR should work with institutions to educate department 
chairs, division chiefs, and fellowship directors about the needs of young investigators and 
how to best support them and provide support for young investigators from institutions 
without strong research enterprises.
When asked which formats are best for presentation of career development programs, 
workshops or seminars, sessions at the ACR/AHRP Annual meeting, and networking 
opportunities were selected by over half of participants (Figure 3).
DISCUSSION
In this mixed methods study, we report the perceived barriers and facilitators to a career in 
rheumatology research among young investigators, fellows, mentors, established 
investigators, and those who have left a career in research. Our qualitative and quantitative 
results confirmed previous findings that research funding is a major concern for 
investigators of in fields, particularly given increased competition for dwindling NIH 
funding.(2) However, protected research time, protection from clinical duties, and 
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mentorship frequently ranked as important barriers and/or facilitators. Examination of 
reasons rheumatologists left research also revealed the importance of institutional support.
To our knowledge, this is the first study to examine barriers and facilitators to a career as a 
physician-scientist in the United States from the perspectives of diverse constituencies 
including young investigators, mentors, fellows and those who decided to leave a career in 
research. Additionally, this is the first study to examine reasons for leaving a career in 
rheumatology research. Strengths of this study include the development of survey items 
using the Delphi technique and the relatively large number of responders (although small 
proportion of the ACR), many of which provided very detailed and specific comments.
The Early Career Professional Section of the American College of Cardiology recently 
conducted a similar survey of early career academicians in their field and found very similar 
results to those presented in our study including insufficient funding, clinical workload, and 
lack of institutional commitment as major barriers to a career in research.(5) A handful of 
other studies have indicated funding(5–7), mentoring (5,6,8,9), clinical work load and focus 
on clinical productivity(5,7,10), lack of protected time(5,11), economic disadvantage to a 
career in research(5,10,11), lack of institutional support and resources(5,6,10), 
organizational problems(7), lack of availability of collaborators(5), lack of support for 
women(7), personal attributes(6), and concerns about career sustainability(9) are influential 
in pursing or maintaining research careers.
Attracting rheumatology fellows into a career in research is also important. A study by the 
ACR Young Investigators Committee in 2009 examined rheumatology fellows’ perceptions 
of a career in research and demonstrated the fellows view a research career path as “high-
risk.”(12) Fellows noted barriers to an academic rheumatology career path focused on 
funding issues including decreased federal funding for research, increasing competition for 
foundation funding, and tightening budgets at academic institutions but also concerns about 
the incompatibility of family life and academia. The latter concern about incompatibility 
with family life is a particular concern given the increasing number of women in 
rheumatology(3,13) Previous studies have suggested that effective mentorship is particularly 
important for the career development of women.(14)
Limitations of our study include potential responder bias, low response rate, bias in item 
selection, and misinterpretation of survey questions. As with all surveys, there may be 
responder bias, particularly in this case as more investigators than clinicians and more 
academicians than non-academic rheumatologists responded. It may be that those who 
responded were more likely to have strong opinions. Similarly, some participants could have 
participated more than once and, given the anonymity of participants, we may have missed 
some duplicates. We excluded responses in which the demographics were identical and the 
comments were nearly identical. Next, in building the items for the survey, we performed a 
Delphi exercise among the ECI subcommittee, all of whom are Assistant Professors 
devoting the majority of their time to research. This may have biased the results obtained. 
Additionally, question order or grouping may have influenced answer selection. We 
addressed these risks by seeking additional comments.
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Participants noted several potential solutions to the mentioned barriers including 1) 
development of a formal cross-institutional mentoring network; 2) lobbying for increased 
NIH funding; 3) working with institutions to educate division chiefs and fellowship directors 
on the needs of young investigators; 4) providing more career development training 
including topics such as grant writing, how to be a mentee, providing example career paths 
and assistance in developing career development plans, balancing clinical duties and 
research activities, developing collaborations, time management, and skill based training; 
and 5) creation of a list serve or community for young investigators to network and share 
common experiences and advice. Additional solutions suggested by other studies include 
potential changes to NIH funding mechanisms such as reinstitution of a specific R-award for 
K-awardees attempting to achieve R-funding for the first time (15), institutional support in 
the way of child care services and mentoring for individuals struggling with work-life 
balance(13), creating and seeking new funding mechanisms through partnerships with 
industry and non-profit organizations(5), and increasing research opportunities during 
fellowship.(5)
In summary, in order to attract young investigators into rheumatology research and sustain 
their careers, knowledge of the obstacles faced and the elements that facilitate career 
persistence are critical. This study revealed that funding and mentoring are the two greatest 
resources for young investigators but that numerous other factors play a role in the 
development and sustenance of an investigator. Protection from excessive clinical and 
administrative duties is also important particularly early in the investigator’s career when he 
or she is gaining the necessary skills to facilitate success. Many of the barriers and 
facilitators identified are dependent on institution-specific resources and personal 
characteristics and situations. However, informing young investigators about how to locate 
and leverage such resources and how to find support for individual circumstances may 
improve the landscape for young investigators. Improved and more wide-reaching 
mentoring could potentially have a large impact on some of the barriers noted. In partnership 
with the Childhood Arthritis and Rheumatology Research Alliance (CARRA), the ACR 
developed the ACR/CARRA Mentoring Interest Group (AMIGO), a novel program aimed at 
matching pediatric rheumatology fellows and junior faculty with mentors of similar interests 
at other institutions.(16) This model has been successful and could potentially be expanded 
to include adult rheumatologists. With that being said, participants recognized that mentors 
need protected time, funding, and recognition for their efforts.(17)
As the American medical system continues to evolve in the next decade, the challenges 
facing young investigators will likewise evolve. The American College of Rheumatology 
has made support for young investigators a significant part of their mission. A continued 
effort to address and meet the needs of young investigators and established investigators 
who serve as their mentors is critical to maintaining the physician scientist workforce in 
rheumatology and supporting advancements in our understanding of the etiology and 
optimal treatment of the rheumatic diseases.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• The physician-scientist workforce is aging, fewer young investigators are 
entering the workforce, and maintaining a career in research is challenging. This 
is the first study to examine barriers and facilitators of sustaining a career in 
rheumatology research and reasons for leaving a career in rheumatology 
research.
• While funding is a major barrier (or facilitator) of a career in research, 
mentoring is critical to the development and sustenance of a career in 
rheumatology research.
• Protected research time, protection from clinical and administrative duties, 
personal characteristics, passion for the job, and institutional support were also 
highly ranked facilitators of a successful career in rheumatology research.
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Figure 1. Barriers to a Career in Research
Among all survey participants, the most commonly sited barriers are shown here for all 
participants and then subgroups of participants. The x-axis shows the percentage of 
participants ranking each item as important (defined as ranking the item as 1, 2, or 3 of 10). 
The barriers are split into the following categories: F: Funding, J: Job Duties, M: Mentoring 
and Networking, O: Outside Influences, I: Institution, P: Personal skills and characteristics. 
Additional barriers and p-values for differences between groups are included in 
Supplemental Table 1.
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Figure 2. Facilitators of a Career in Research
Among all survey participants, the most commonly sited facilitators are shown here for all 
participants and then subgroups of participants. The x-axis shows the percentage of 
participants ranking each item as important (defined as ranking the item as 1, 2, or 3 of 10). 
The barriers are split into the following categories: F: Funding, J: Job Duties, M: Mentoring 
and Networking, O: Outside Influences, I: Institution, P: Personal skills and characteristics. 
Additional facilitators and p-values for differences between groups are included in 
Supplemental Table 1.
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Figure 3. Formats most useful for presentation of career development and research training 
initiatives
Participants were asked to select formats for presentation of information relevant to career 
development and research training for young investigators. Young investigators and mentors 
identified similar formats as being useful except that young investigators more often 
selected web-based formats compared to mentors.
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Table 1
Demographics of Survey Participants with Complete Data (N=430)
Current Position Adult Rheumatologist 309 (72%)
Pediatric Rheumatologist 62 (14%)
Adult Fellow 42 (10%)
Pediatric Fellow 17 (4%)
Place of Employment Academic Medical Center 306 (71%)




Academic Appointment Instructor or other Junior Faculty 34 (8%)
Assistant Professor 102 (24%)
Associate Professor 58 (13%)
Professor 89 (21%)
Other or Not Applicable 147 (34%)









Female Sex N (%) 241 (56%)
Medical School in the US N (%) 318 (74%)
Underrepresented Minority* N (%) 28 (7%)




Successful Funding Foundation fellowship/post–doc award 92 (21%)
Foundation career development award 99 (23%)
NIH Loan Repayment Program 24 (6%)
NIH K-series or VA career development award 76 (18%)
NIH R01 59 (14%)
Other NIH awards 71 (17%)
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Any other grants 141 (33%)
Current Researcher Total 171 (40%)
Young Investigator 88 (20%)
Mentor to Young Investigator 76 (18%)
Research effort ≥ 50% 134 (31%)
Research effort ≥ 70% 100 (23%)
Type of Research‡ Clinical 88 (51%)
Epidemiology/Health Services 18 (11%)
Translational 99 (58%)
Basic Science 53 (31%)
All percentages are of the total N=430.
*
An “under-represented minority within rheumatology” was defined as Black, Hispanic, or Native American (that is, American Indians, Alaska 
Natives, and Native Hawaiians). This information has not been collected among ACR members in general. However, among early career 
rheumatologists in the Rheumatology Workforce Survey, approximately 9.7% ascribed to similar categories (Desjardin et al, 2010).
†
Effort estimates exclude fellows
‡
Among those engaged in research currently (N=171), more than one answer participant was allowed so the total adds to greater than 100%.
Abbreviations: NIH = National Institutes of Health
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Table 2
Participants who decided to leave a research career (N=97)
Characteristic Median (IQR) or N(%)
Female Sex 45 (46%)
Year Since Transition 10 (IQR 3–20)
Year of fellowship completion (median and IQR) 1993 (IQR 1983–2005)
Years after fellowship when transition occurred (median and IQR) 7 (2–14)
Current Position Adult Rheumatologist 78 (80%)
Pediatric Rheumatologist 14 (14%)
Adult Fellow 5 (5%)
Pediatric Fellow 0 (0%)
Place of Employment Academic Medical Center 52 (54%)




Academic Appointment (current) Instructor or other Junior Faculty 6 (6%)
Assistant Professor 14 (14%)
Associate Professor 21 (22%)
Professor 22 (23%)
Other or Not Applicable 34 (35%)
Previous Type of Research Clinical 47 (48%)
Epidemiology/Health Services 8 (8%)
Translational 36 (37%)
Basic Science 49 (51%)
Factors Contributing to Decision to Leave
Difficulty obtaining grant funding 55 (57%)
Lack of division/department support 51 (53%)
Better compensation 38 (39%)
Lack of mentorship 38 (39%)
Tired of writing grants 33 (34%)
Personal reasons* 26 (27%)
Desire to spend more time in clinical care 20 (21%)
Exciting opportunities in industry 10 (10%)
Did not enjoy research work 6 (6%)
What would have retained you in a research career?
Provide internal grant funding mechanisms 54 (56%)
Increase protected time 50 (52%)
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Characteristic Median (IQR) or N(%)
Increase income 31 (32%)
Increase work flexibility 25 (26%)
Provide greater leadership opportunities 25 (26%)
Nothing would have incentivized me to stay in academics 9 (9%)
*
Personal reasons included desire to move geographically (N=16) or desire to spend more time with family (N=15).
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Table 3
Themes Derived from Content Analysis of Free Text Comments
Theme N (%)
Funding 299 (70%)
Early career and young investigator grants 62 (14%)
Bridge funding (before K-award, between K-award and R01 or between R01s) 32 (7%)
Pilot grants and smaller project funding 19 (4%)
ACR should advocate for more federal funding 18 (4%)
Need more federal funding 17 (4%)
Loan repayment programs 14 (3%)
Mid-career funding 13 (3%)
Funds for research assistant or startup funds 11 (3%)
Funding for non-US citizens 6 (1%)
Increase salary support in grants 5 (1%)
Partner with other organizations 5 (1%)
Promote the success of rheumatology research (both ACR and NIAMS funded) 4 (1%)
Find more donors 3 (1%)
Career re-entry awards 2 (0.5%)
Mentoring 135 (31%)
Develop structured mentoring networks 48 (11%)
Fund and support mentors 16 (4%)
Mentor training 6 (1%)
Career Development and Skill Building 211 (49%)
Increase opportunities for networking 57 (13%)
Grant writing support and/or workshops 44 (10%)
Host programs and workshops for career development 41 (10%)
Disseminate information about resources for young investigators including funding opportunities, job opportunities, research 
initiatives, research needs in the field using the website, interactive media including webinars, online forums, and email 
distribution lists.
21 (5%)
Assist investigators with the K to R transition 20 (5%)
Help young investigators develop their research focus and ideas 17 (4%)
Support formal research training (e.g. Masters programs) 16 (4%)
Training in career skills such as presentation skills, leadership development and negotiation 14 (3%)
Provide example career paths and assist in assessing career path 14 (3%)
Create a community for young investigators 14 (3%)
Specific training in research skills such as basic biostatistics, clinical trials training, navigation of the research environment (e.g. 
IRBs, MTA), and research professionalism (e.g. guidelines for authorship)
12 (3%)
Support research fellowships and/or time in another lab 8 (2%)
Encourage early participation in the ACR 8 (2%)
Help individuals assess their own skills 5 (1%)
Provide access to resources such as statistical support, data, etc. 3 (1%)
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Theme N (%)
Increase interest in and sustainability of research as a career 117 (27%)
Increase research training in fellowship starting at the beginning of fellowship 31 (7%)
More protected time 31 (7%)
Better compensation 21 (5%)
Provide early research experience for undergraduates, medical students, residents and fellows. 20 (5%)
Encourage cross-institutional collaboration 16 (4%)
Salary security 15 (4%)
Foster the development of the next generation of rheumatologists (both clinical and research) 12 (3%)
Non-traditional career paths to keep investigators in academics and research (e.g. part time for parents with young children). 2 (1%)
Improve the Research Environment for Young Investigators 71 (17%)
Support clinicians who in turn can help support research 25 (6%)
Support young investigators from institutions without solid research infrastructure and mentors 14 (3%)
Educate division chiefs and fellowship directors about how to best support young investigators 10 (2%)
Provide advice or mediation for young investigators in conflict situations 4 (1%)
Improve study sections at NIH 4 (1%)
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